Hemispherx BioPharma competitors

Hemispherx BioPharma's competitors include Alimera Sciences, MyoKardia, Athersys and Ironwood Pharmaceuticals
Add company...
Hemispherx BioPharma
Hemispherx Biopharma, Inc. is an advanced specialty pharmaceutical company engaged in the clinical development of new drug entities for treatment of seriously debilitating disorders.
Alimera Sciences
Alimera Sciences is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals.
MyoKardia
MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.
Athersys
Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.
Founding Date
Founding Date
1990
Founding Date
2003
Founding Date
2012
Founding Date
1995
Founding Date
N/A
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Philadelphia, US HQ
Philadelphia, US
Locations
Alpharetta, US HQ
Berlin, DE
Lisbon, PT
Hampshire, GB
Locations
South San Francisco, US HQ
Locations
Cleveland, US HQ
Canton, US
Locations
Cambridge, US HQ
Employees
Employees
32
Employees
125
Employees
1024% increase
Employees
60
Employees
674
Valuation ($)
Valuation ($)
11.3 m
Valuation ($)
72.8 m
Valuation ($)
2.5 b
Valuation ($)
268.9 m
Valuation ($)
2.6 b
Facebook likes
Facebook likes
N/A
Facebook likes
3.4 k
Facebook likes
N/A
Facebook likes
475
Facebook likes
18
Twitter followers
Twitter followers
N/A
Twitter followers
1.7 k
Twitter followers
387
Twitter followers
953
Twitter followers
3.1 k

Financial

Revenue (est.)
Revenue (est.)
$92k (FY, 2016)
Revenue (est.)
$34.3m (FY, 2016)
Revenue (est.)
$22.5m (FY, 2017)
Revenue (est.)
$3.7m (FY, 2017)
Revenue (est.)
$274m (FY, 2016)
Net income
Net income
($7.5m) (FY, 2016)
Net income
($33.2m) (FY, 2016)
Net income
($46m) (FY, 2017)
Net income
N/A
Net income
($81.7m) (FY, 2016)

Operating

Patents (US)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
4 (FY, 2017)
Patents (US)
21 (FY, 2016)
Patents (US)
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 93.6m
Total funding raised
$ 98m
Total funding raised
$ 9m
Total funding raised
$ 284m
For sources of this data, please see the company profileDownload Excel

View company profiles

Alimera Sciences
HQ
Alpharetta, US
Employees
125

Alimera Sciences is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals.

View company
MyoKardia
HQ
South San Francisco, US
Employees
102↑ 4% increase

MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

View company
Athersys
HQ
Cleveland, US
Employees
60

Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.

View company
Ironwood Pharmaceuticals
HQ
Cambridge, US
Employees
674

Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company, develops drugs for gastrointestinal and cardiovascular diseases.

View company